Lilly To Bring Forward Alzheimer’s Readout
Gamble By Rivals Biogen Is Likely Inspiration
After years of failure, expectations of solanezumab are very low – but Lilly still hoping for a signal.
You may also be interested in...
The FDA has overcome doubts about the drug's safety and reversed its decision in just four months.
The Coalition for Epidemic Preparedness Innovations adds new deal with mRNA specialist Moderna for rapid development of coronavirus vaccine.